BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20880838)

  • 1. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
    Gaiser AM; Kretzschmar A; Richter K
    J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
    Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
    J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
    Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
    J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
    Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
    J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle.
    Siligardi G; Hu B; Panaretou B; Piper PW; Pearl LH; Prodromou C
    J Biol Chem; 2004 Dec; 279(50):51989-98. PubMed ID: 15466438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37.
    Siligardi G; Panaretou B; Meyer P; Singh S; Woolfson DN; Piper PW; Pearl LH; Prodromou C
    J Biol Chem; 2002 Jun; 277(23):20151-9. PubMed ID: 11916974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
    Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
    J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide-Free sB-Raf is Preferentially Bound by Hsp90 and Cdc37 In Vitro.
    Eckl JM; Daake M; Schwartz S; Richter K
    J Mol Biol; 2016 Oct; 428(20):4185-4196. PubMed ID: 27620500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A primate specific extra domain in the molecular chaperone Hsp90.
    Tripathi V; Obermann WM
    PLoS One; 2013; 8(8):e71856. PubMed ID: 23951259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atomistic simulations and network-based modeling of the Hsp90-Cdc37 chaperone binding with Cdk4 client protein: A mechanism of chaperoning kinase clients by exploiting weak spots of intrinsically dynamic kinase domains.
    Czemeres J; Buse K; Verkhivker GM
    PLoS One; 2017; 12(12):e0190267. PubMed ID: 29267381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p23 and Aha1: Distinct Functions Promote Client Maturation.
    Biebl MM; Buchner J
    Subcell Biochem; 2023; 101():159-187. PubMed ID: 36520307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
    Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L
    Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Regulation of G1 CDK Complexes by the Hsp90-Cdc37 Chaperone System.
    Hallett ST; Pastok MW; Morgan RML; Wittner A; Blundell KLIM; Felletar I; Wedge SR; Prodromou C; Noble MEM; Pearl LH; Endicott JA
    Cell Rep; 2017 Oct; 21(5):1386-1398. PubMed ID: 29091774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'active life' of Hsp90 complexes.
    Prodromou C
    Biochim Biophys Acta; 2012 Mar; 1823(3):614-23. PubMed ID: 21840346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.
    Meyer P; Prodromou C; Liao C; Hu B; Roe SM; Vaughan CK; Vlasic I; Panaretou B; Piper PW; Pearl LH
    EMBO J; 2004 Mar; 23(6):1402-10. PubMed ID: 15039704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of serine 13 is required for the proper function of the Hsp90 co-chaperone, Cdc37.
    Shao J; Prince T; Hartson SD; Matts RL
    J Biol Chem; 2003 Oct; 278(40):38117-20. PubMed ID: 12930845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the weak ATPase activity of human hsp90 by a client protein.
    McLaughlin SH; Smith HW; Jackson SE
    J Mol Biol; 2002 Jan; 315(4):787-98. PubMed ID: 11812147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp90 structure and function studied by NMR spectroscopy.
    Didenko T; Duarte AM; Karagöz GE; Rüdiger SG
    Biochim Biophys Acta; 2012 Mar; 1823(3):636-47. PubMed ID: 22155720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thr90 phosphorylation of Hsp90α by protein kinase A regulates its chaperone machinery.
    Wang X; Lu XA; Song X; Zhuo W; Jia L; Jiang Y; Luo Y
    Biochem J; 2012 Jan; 441(1):387-97. PubMed ID: 21919888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.